Science updates
17 Dec 2024
ISTH 2024 Congress catch up on the latest data and insights into gene therapy for haemophilia B
In June, the International Society on Thrombosis and Haemostasis (ISTH) 2024 Congress took place in Bangkok, Thailand, where CSL Behring sponsored the symposium 'Building momentum to raise the standard of care in bleeding disorders' and product theatre 'Learning through shared experience: Gene therapy for haemophilia B'.
The expert faculty of the educational symposium, David Lillicrap (Canada), Ampaiwan Chuansumrit (Thailand), Pratima Chowdary (UK) and Robert Klamroth (Germany), took the audience on a journey exploring innovations in the treatment and diagnosis pathways of bleeding disorders, including haemophilia B and von Willebrand disease, where they explored how small steps can result in big leaps for patient care.
